Jundishapur Journal of Microbiology

Scope & Guideline

Nurturing a community dedicated to microbial discovery.

Introduction

Delve into the academic richness of Jundishapur Journal of Microbiology with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2008-3645
PublisherBRIEFLAND
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2009 to 2024
AbbreviationJUNDISHAPUR J MICROB / Jundishapur J. Microbiol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address25 Derde Morgen , Shertogenbosch 5233 NL, NETHERLANDS

Aims and Scopes

The Jundishapur Journal of Microbiology primarily focuses on the study of microorganisms and their interactions with human health, the environment, and disease pathogenesis. The journal emphasizes innovative research methodologies and the development of new diagnostic and therapeutic strategies.
  1. Microbiological Pathogenesis and Disease:
    Research focusing on the role of various microorganisms in human diseases, including bacterial, viral, and fungal infections. Studies often explore the mechanisms of pathogenicity and host-pathogen interactions.
  2. Antimicrobial Resistance:
    A significant emphasis on the emergence and mechanisms of resistance in pathogens, particularly focusing on multidrug-resistant strains and the genetic basis of resistance mechanisms.
  3. Clinical Microbiology and Infectious Diseases:
    Investigations into clinical cases, epidemiological studies, and the characterization of microbial infections in different populations, including children and immunocompromised patients.
  4. Diagnostic Innovations:
    Development and evaluation of new diagnostic methods, including molecular techniques, to improve the identification and management of infectious diseases.
  5. Environmental Microbiology:
    Research on the microbial diversity in various environments, including clinical settings, and the impact of microorganisms on public health.
  6. Therapeutic Approaches:
    Exploration of new therapeutic agents, including the use of phages, probiotics, and novel compounds to combat infections and improve treatment outcomes.
The Jundishapur Journal of Microbiology has seen a rise in several emerging themes, reflecting current global health challenges and advancements in microbiological research.
  1. COVID-19 Related Research:
    A significant increase in studies related to COVID-19, including its clinical impacts, associated infections, and immune responses. This trend highlights the ongoing global health crisis and its implications for microbiology.
  2. Molecular Characterization and Genomics:
    Emerging focus on the genomic characterization of pathogens to understand their resistance mechanisms and virulence factors, reflecting advancements in sequencing technologies.
  3. Biomarkers for Disease Severity:
    Growing interest in identifying biomarkers associated with the severity of infectious diseases, particularly for COVID-19 and other viral infections, which can aid in prognosis and treatment.
  4. Therapeutic Drug Monitoring and Personalized Medicine:
    Increasing research on therapeutic drug monitoring, particularly in pediatric and immunocompromised populations, indicating a trend towards personalized treatment strategies.
  5. Novel Antimicrobial Strategies:
    Emerging studies on innovative therapeutic approaches, including the use of phage therapy, antimicrobial peptides, and natural products, to combat resistant strains.

Declining or Waning

While the Jundishapur Journal of Microbiology has a broad range of research topics, certain themes have shown a decline in prominence in recent years. This may reflect shifts in research funding, public health priorities, or emerging scientific interests.
  1. Traditional Antibiotic Studies:
    There has been a noticeable reduction in studies focused solely on traditional antibiotics without exploring multidrug resistance or novel therapeutic approaches. This shift indicates a growing awareness of the limitations of existing antibiotics.
  2. Non-Clinical Microbiology:
    Research that previously focused on non-clinical settings, such as environmental or industrial microbiology, is less frequently reported, suggesting a shift towards clinical applications and human health.
  3. Basic Microbial Ecology:
    Basic studies on microbial ecology and diversity without direct clinical relevance have decreased, possibly due to increased emphasis on translational research that directly impacts patient care.

Similar Journals

JOURNAL OF INFECTION

Connecting Researchers and Clinicians in Infection Science
Publisher: W B SAUNDERS CO LTDISSN: 0163-4453Frequency: 12 issues/year

JOURNAL OF INFECTION is a premier academic publication in the fields of infectious diseases and medical microbiology, published by W B SAUNDERS CO LTD. With a profound impact factor and established since 1979, this journal serves as a crucial resource for researchers, clinicians, and policy-makers seeking to advance knowledge and understanding of infectious processes and their management. The JOURNAL OF INFECTION holds an impressive position in the academic hierarchy as reflected by its Q1 quartile rankings in both Infectious Diseases and Microbiology (medical) for 2023, further underscored by its Scopus rankings: #2 in Medical Microbiology and #5 in Medical Infectious Diseases, placing it in the 98th percentile overall. While the journal does not offer Open Access options, it provides a comprehensive outlet for innovative research, reviews, and clinical insights that drive the field forward. Published from the United Kingdom, it attracts a global readership keen on staying at the forefront of infectious disease research, making it an essential addition to any academic and clinical library.

ARCHIVES OF MICROBIOLOGY

Bridging Disciplines, Inspiring Discoveries
Publisher: SPRINGERISSN: 0302-8933Frequency: 12 issues/year

The Archives of Microbiology, published by Springer, is a reputable journal in the field of microbiology, serving as a vital platform for the dissemination of groundbreaking research and critical reviews since its inception in 1974. With an ISSN of 0302-8933 and an E-ISSN of 1432-072X, this journal operates out of Germany and maintains a global reach, promoting high-quality scholarship across multiple disciplines, including biochemistry, genetics, and molecular biology, as evidenced by its Q2 ranking in Medicine (miscellaneous) and consistent Q3 placements in other categories in 2023. Although the journal does not offer open access options, its rigorous peer-review process ensures that published articles are of the highest standard, making it an essential resource for researchers, professionals, and students keen on advancing their understanding of microbial sciences. As the journal converges toward 2024, it remains committed to fostering innovative microbiological research and facilitating interdisciplinary dialogue within the scientific community.

MIKROBIYOLOJI BULTENI

Fostering Knowledge in Immunology and Microbiology
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

Frontiers in Cellular and Infection Microbiology

Pioneering research for a healthier tomorrow.
Publisher: FRONTIERS MEDIA SAISSN: 2235-2988Frequency: 1 issue/year

Frontiers in Cellular and Infection Microbiology, published by FRONTIERS MEDIA SA, is a leading Open Access journal that has been at the forefront of microbiological research since 2011. Located in Switzerland, this journal aims to provide a platform for innovative and impactful studies in various domains including immunology, infectious diseases, and medical microbiology. With an impressive range of quartile rankings—Q1 in Infectious Diseases, Microbiology, and Microbiology (medical), and Q2 in Immunology—as of 2023, it positions itself as a highly reputable source in the academic community. Furthermore, its Scopus rankings highlight its significance within the respective fields, with top percentiles in key categories, making it an essential resource for researchers, professionals, and students alike. As an Open Access publication, it ensures that vital findings are accessible to a global audience, fostering collaboration and advancement in science.

Mediterranean Journal of Infection Microbes and Antimicrobials

Advancing knowledge in infection and microbiology.
Publisher: GALENOS PUBL HOUSEISSN: 2147-673XFrequency: 1 issue/year

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

MICROBIAL PATHOGENESIS

Pioneering Research in Microbial Pathogenesis
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 0882-4010Frequency: 12 issues/year

MICROBIAL PATHOGENESIS, published by Academic Press Ltd - Elsevier Science Ltd, is a prominent journal in the fields of Infectious Diseases and Microbiology, with a notable impact factor and classified in the Q2 quartile for both categories as of 2023. Since its inception in 1986, this journal has provided a platform for the dissemination of cutting-edge research that enhances our understanding of microbial infections and their implications in health and disease. The journal is indexed in Scopus, ranking #80 among 344 in Infectious Diseases and #57 among 182 in Microbiology, underscoring its significant contribution to the scientific community. Although it operates under a traditional subscription model, the content is vital for researchers, professionals, and students focused on the dynamics of microbial pathogenesis and the development of innovative therapeutic strategies. The journal's comprehensive scope aims to foster advancements in this critical area of study, bridging the gap between laboratory research and clinical applications.

BRAZILIAN JOURNAL OF MICROBIOLOGY

Championing Open Access to Microbial Discoveries
Publisher: SPRINGERISSN: 1517-8382Frequency: 4 issues/year

The BRAZILIAN JOURNAL OF MICROBIOLOGY, published by SPRINGER, stands as a pivotal platform in the field of microbiology, offering an open access model since 2000. With the ISSN 1517-8382 and E-ISSN 1678-4405, this esteemed journal encourages the dissemination of groundbreaking research and innovative methodologies that contribute to the understanding of microbial life, its role in health and disease, and its environmental impact. Based in Switzerland and accessible globally, the journal’s categorization in the Q3 quartile for Microbiology reflects its commitment to quality and relevance in the scientific community. As of 2023, it ranks 121 out of 182 in the Scopus listings for Microbiology, further highlighting its growing influence in immunology and microbiological research. With converged years spanning from 1992 to 2024, the journal continues to support a diverse range of studies, making it an invaluable resource for researchers, professionals, and students alike.

GERMS

Enhancing public health through collaborative research initiatives.
Publisher: EUROPEAN ACAD HIV-AIDS & INFECTIOUS DISEASESISSN: 2248-2997Frequency: 4 issues/year

GERMS is a multidisciplinary journal published by the EUROPEAN ACAD HIV-AIDS & INFECTIOUS DISEASES, dedicated to advancing knowledge in the fields of epidemiology, immunology, infectious diseases, and microbiology. Since its inception in 2011, the journal has provided a crucial platform for researchers and practitioners to share innovative studies, clinical findings, and public health insights, with an eye on improving health outcomes globally. With an ISSN of 2248-2997 and a consistent publication trajectory leading up to 2024, GERMS is recognized in the third quartile across several categories, reflecting its growing impact and relevance in the scientific community. Authors and readers benefit from a range of access options, fostering the dissemination of vital research findings. As a journal situated in Romania, it also addresses regional health challenges while contributing to the broader discourse on infectious diseases and public health. GERMS is not just a repository of knowledge, but a vital resource for those engaged in combating infectious diseases and promoting health equity.

MicrobiologyOpen

Unlocking the frontiers of microbiology through open access.
Publisher: WILEYISSN: 2045-8827Frequency: 12 issues/year

MicrobiologyOpen is a prestigious, open access journal published by WILEY, dedicated to advancing the field of microbiology. Since its inception in 2012, this journal has firmly established itself as a significant platform for researchers, professionals, and students alike, facilitating the dissemination of high-quality research findings across a wide range of microbiological disciplines. With an impressive impact factor and a ranking in the 76th percentile of Scopus for immunology and microbiology, MicrobiologyOpen offers a robust forum for innovative studies, reviews, and compelling insights that push the boundaries of scientific understanding. The journal's commitment to open access ensures that groundbreaking research is freely available to the global community, fostering collaboration and knowledge-sharing. As it continues to evolve until 2024, MicrobiologyOpen remains pivotal for anyone looking to stay at the forefront of microbiological research.

Reviews and Research in Medical Microbiology

Advancing the Frontiers of Medical Microbiology
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2770-3150Frequency: 4 issues/year

Reviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.